Amgen Ventures, formed in 2004, is the corporate venture fund of Amgen. With an initial investment of $100 million, the fund is designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. Amgen Ventures reflects Amgen's commitment to helping patients by transforming cutting-edge scientific discoveries into novel treatments for serious illness. As an important component of Amgen's overall outreach strategy, Amgen Ventures in...Show all

Amgen Ventures, formed in 2004, is the corporate venture fund of Amgen. With an initial investment of $100 million, the fund is designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human the...Show all

See All Exits Recent Exits

Phone:

Fax:

1 Amgen Center Drive

Thousand Oaks, 91320
California, United States

Amgen Ventures - Investments & Acquisitions

Show Real Data Amgen Ventures Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-11-13RibometrixSeries A$30MAbbVie Biotech Ventures, Alexandria Venture Investments, Dementia Discovery Fund, Hatteras Venture Partners, Illumina Ventures, Merck Ventures, MP Healthcare Venture Management, Pappas Ventures, and SV Health Investors
2018-07-25AlectorSeries E$133MAbbVie Biotech Ventures, Casdin Capital, Deerfield Management, Dementia Discovery Fund, Euclidean Capital, Federated Equity Funds - Federated Kaufmann Fund, Foresite Capital, Google Ventures, Lilly Asia Ventures, Mission Bay Capital, MRL Ventures, New Leaf Venture Partners, OrbiMed Advisors, Perceptive Advisors, Polaris Partners, and Section 32
2018-06-08Precision BioSciencesSeries B$110MAdage Capital Management, Agent Capital, Alexandria Venture Investments, ArrowMark Partners, Brace Pharma Capital, Cormorant Asset Management, Cowen Group, DUMAC, F-Prime Capital, Franklin Templeton Investments, Gilead Sciences, Leerink Partners, OCV Partners, Osage University Partners, Pontifax AgTech, RA Capital Management, Ridgeback Capital Management, The Longevity Fund, venBIO, and Vivo Capital
2018-06-06Sutro BiopharmaSeries E$85.4MAlta Partners, Celgene, Citadel, Eventide Asset Management, Lilly Ventures, Merck Ventures, Nexthera Capital, Samsara BioCapital, Skyline Ventures, SV Health Investors, Tekla Capital Management, and Vida Ventures
2018-05-09Akili Interactive LabsSeries C$55MBaillie Gifford & Co., Brooklands Capital Strategies, Canepa Advanced Healthcare Fund, Jazz Venture Partners, Merck Ventures, and Temasek Holdings
See all 5 investments